Micro-helix
Latest round
- Series A
Last raised
- Aug 2016
Total raised
- Undisclosed
Investors
- 5
About Micro-helix
Established in 2014 and based in Beijing, China, Micro-helix operates a medical and health services company that provides genetic testing services for hereditary medication. Micro-helix focuses on providing services such as hereditary cardiovascular disease, drug genetic testing, NIPT testing, bone tumor and drug genetic testing, genomics research, transcriptomics research and other services. Products include genetic workstations, genetic operating systems, genetic databases, and genetic big data cloud platform services, as well as genetic training courses and other services.
Who invested in Micro-helix
5 investors across 2 rounds
See all investors in Micro-helix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Micro-helix
Who invested in Micro-helix?
Micro-helix has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Micro-helix raised?
Micro-helix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Micro-helix last raise money?
Micro-helix's most recent round on record is a Series A, in Aug 2016.
What does Micro-helix do?
Established in 2014 and based in Beijing, China, Micro-helix operates a medical and health services company that provides genetic testing services for hereditary medication.
Where is Micro-helix headquartered?
Micro-helix is headquartered in Beijing, China.
Which VCs invest in companies like Micro-helix?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Micro-helix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Micro-helix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.